Safety and efficacy of sitagliptin in patients with type 2 diabetes and chronic renal insufficiency

磷酸西他列汀 医学 肾功能 安慰剂 内科学 磷酸西他列汀 肾脏疾病 2型糖尿病 人口 透析 格列吡嗪 胃肠病学 糖尿病 泌尿科 内分泌学 病理 替代医学 环境卫生
作者
Juliana C.N. Chan,Russell Scott,Juan Camilo Arjona Ferreira,Pei Chia Eng,Edward J. Gonzalez,Michael J. Davies,Peter P. Stein,Keith D. Kaufman,John M. Amatruda,Debora Williams‐Herman
出处
期刊:Diabetes, Obesity and Metabolism [Wiley]
卷期号:10 (7): 545-555 被引量:236
标识
DOI:10.1111/j.1463-1326.2008.00914.x
摘要

To assess the safety of sitagliptin in patients with type 2 diabetes and moderate [creatinine clearance (CrCl) > or =30 to <50 ml/min] or severe renal insufficiency [CrCl <30 ml/min including patients with end-stage renal disease (ESRD) on dialysis]. The efficacy of sitagliptin in this patient population was also assessed.In a 54-week, randomized, double-blind, parallel-group study, patients with baseline glycosylated haemoglobin A(1c) (HbA(1c)) values of 6.5-10% were allocated (2:1) to sitagliptin (for 54 weeks) or the sequence of placebo (for 12 weeks) followed by active treatment with glipizide (for 42 weeks). To achieve plasma concentrations similar to those observed in patients with normal renal function treated with 100 mg sitagliptin once daily, patients with moderate renal insufficiency were allocated to receive sitagliptin 50 mg once daily and patients with severe renal insufficiency to receive 25 mg once daily. Glipizide treatment was initiated at 2.5 or 5 mg/day and uptitrated to a maximum of 20 mg/day.Patients (N = 91) with a mean baseline HbA(1c) value of 7.7% (range: 6.2-10.3%) were randomized to sitagliptin (n = 65) or placebo (n = 26). After 12 weeks, the mean change [95% confidence interval (CI)] from baseline in HbA(1c) was -0.6% (-0.8, -0.4) in the sitagliptin group compared with -0.2% (-0.4, 0.1) in the placebo group [between-group difference (95% CI) = -0.4% (-0.7, -0.1)]. At 54 weeks, patients continuously treated with sitagliptin had a mean change (95% CI) from baseline in HbA(1c) of -0.7% (-0.9, -0.4). The overall incidence of adverse experiences was generally similar between groups. Between-group differences in incidences of specific clinical adverse experiences were generally small; however, the proportion of patients for whom hypoglycaemia was reported was lower in the sitagliptin group (4.6%) compared with the placebo/glipizide group (23.1%). Consistent with the high mortality risk in this patient population, there were six deaths during this 54-week study [5 of 65 patients (7.7%) in the sitagliptin group and 1 of 26 patients (3.8%) in the placebo/glipizide group]; no death was considered by the investigator to be drug related. The overall incidences of drug-related and serious adverse experiences and discontinuations because of adverse experiences were generally similar between groups.In this study, sitagliptin was generally well tolerated and provided effective glycaemic control in patients with type 2 diabetes and moderate to severe renal insufficiency, including patients with ESRD on dialysis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Culto完成签到,获得积分10
刚刚
1秒前
JIE完成签到,获得积分10
1秒前
houjibofa发布了新的文献求助10
2秒前
田様应助幽默平安采纳,获得10
5秒前
可爱的函函应助刘小小123采纳,获得10
6秒前
瓣落的碎梦完成签到,获得积分0
8秒前
善学以致用应助momo采纳,获得10
9秒前
孝顺的觅风完成签到 ,获得积分10
9秒前
11秒前
刘小小123发布了新的文献求助10
14秒前
健壮的面包完成签到,获得积分10
14秒前
17秒前
孙燕应助科研界的恩希玛采纳,获得20
20秒前
21秒前
迷茫的一代完成签到,获得积分10
23秒前
量子星尘发布了新的文献求助10
23秒前
xingxingwang完成签到,获得积分10
24秒前
春来发布了新的文献求助30
25秒前
26秒前
26秒前
刘小小123完成签到,获得积分20
26秒前
xzy完成签到 ,获得积分10
27秒前
搜集达人应助无情向梦采纳,获得10
29秒前
阿伟1999发布了新的文献求助50
31秒前
momo发布了新的文献求助10
32秒前
li完成签到,获得积分10
33秒前
如此发布了新的文献求助10
35秒前
36秒前
赵静1234567890完成签到,获得积分10
36秒前
xxxllllll发布了新的文献求助10
40秒前
科研通AI2S应助科研通管家采纳,获得10
40秒前
Owen应助科研通管家采纳,获得10
40秒前
乐乐应助科研通管家采纳,获得10
40秒前
科研通AI5应助科研通管家采纳,获得10
40秒前
YamDaamCaa应助科研通管家采纳,获得50
40秒前
科研通AI5应助科研通管家采纳,获得10
40秒前
科目三应助科研通管家采纳,获得10
41秒前
爆米花应助科研通管家采纳,获得10
41秒前
稳重淇完成签到 ,获得积分10
41秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989334
求助须知:如何正确求助?哪些是违规求助? 3531428
关于积分的说明 11253936
捐赠科研通 3270119
什么是DOI,文献DOI怎么找? 1804887
邀请新用户注册赠送积分活动 882087
科研通“疑难数据库(出版商)”最低求助积分说明 809173